Early experience of seven hepatocellular carcinoma cases treated with regorafenib

ανά Uchikawa, Shinsuke, Kawaoka, Tomokazu, Aikata, Hiroshi, Kodama, Kenichiro, Inagaki, Yuki, Hatooka, Masahiro, Morio, Kei, Nakahara, Takashi, Murakami, Eisuke, Hiramatsu, Akira, Tsuge, Masataka, Imamura, Michio, Kawakami, Yoshiiku, Chayama, Kazuaki
Τόπος έκδοσης Clin Case Rep (2018)

Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): an open label, non-comparative, phase II trial

ανά Hatooka, Masahiro, Kawaoka, Tomokazu, Aikata, Hiroshi, Inagaki, Yuki, Morio, Kei, Nakahara, Takashi, Murakami, Eisuke, Tsuge, Masataka, Hiramatsu, Akira, Imamura, Michio, Kawakami, Yoshiiku, Awai, Kazuo, Masaki, Keiichi, Waki, Koji, Kohno, Hirotaka, Kohno, Hiroshi, Moriya, Takashi, Nagaoki, Yuko, Tamura, Toru, Amano, Hajime, Katamura, Yoshio, Chayama, Kazuaki
Τόπος έκδοσης BMC Cancer (2018)

The risks of hepatocellular carcinoma development after HCV eradication are similar between patients treated with peg-interferon plus ribavirin and direct-acting antiviral therapy

ανά Nagaoki, Yuko, Imamura, Michio, Aikata, Hiroshi, Daijo, Kana, Teraoka, Yuji, Honda, Fumi, Nakamura, Yuki, Hatooka, Masahiro, Morio, Reona, Morio, Kei, Kan, Hiromi, Fujino, Hatsue, Kobayashi, Tomoki, Masaki, Keiichi, Ono, Atsushi, Nakahara, Takashi, Kawaoka, Tomokazu, Tsuge, Masataka, Hiramatsu, Akira, Kawakami, Yoshiiku, Hayes, C. Nelson, Miki, Daiki, Ochi, Hidenori, Chayama, Kazuaki
Τόπος έκδοσης PLoS One (2017)